Filter
559
Filtered Results: 559
Text search:
pharmacovigilance
Featured
Recommendations
62
New Publications
167
Language
Document type
No document type
268
Guidelines
114
Studies & Reports
78
Strategic & Response Plan
29
Manuals
27
Fact sheets
16
Resource Platforms
8
Training Material
7
Situation Updates
5
Online Courses
4
Infographics
2
Videos
1
Countries / Regions
Kenya
26
Congo, Democratic Republic of
17
South Africa
17
Ghana
16
India
16
Nigeria
15
Global
14
Western and Central Europe
14
Uganda
14
Senegal
12
Eastern Europe
12
Ethiopia
12
Rwanda
11
Nepal
10
Latin America and the Carribbean
10
Namibia
10
West and Central Africa
9
Sierra Leone
8
Burkina Faso
8
Malawi
8
Africa
8
Tanzania
8
East and Southern Africa
8
Zambia
8
Madagascar
8
Benin
6
Haiti
6
South–East Asia Region
6
Philippines
5
Cambodia
5
Bangladesh
5
Russia
5
Botswana
5
Liberia
5
Middle East and North Africa
4
Ukraine
3
Lesotho
3
Zimbabwe
3
Mozambique
3
Eastern Europe and Central Asia
3
Chile
2
Cameroon
2
Syria
2
Morocco
2
Asia
2
Paraguay
2
Lebanon
2
Brazil
2
Sudan
2
Chad
2
Libya
2
Indonesia
2
Myanmar / Burma
2
Eswatini/ Swaziland
2
Pakistan
2
Thailand
1
Gambia
1
Laos
1
Afghanistan
1
Burundi
1
Guinea
1
Jordan
1
Western Pacific Region
1
France
1
Maldives
1
Southern Africa
1
Argentina
1
Sri Lanka
1
Yemen
1
Georgia
1
Mali
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
282
Clinical Guidelines
64
Public Health
18
Pharmacy & Technologies
10
Capacity Building
9
Women & Child Health
8
Key Resources
3
Toolboxes
Pharmacy
73
COVID-19
62
TB
55
AMR
46
HIV
23
NTDs
22
Ebola
6
Rapid Response
5
Caregiver
5
Planetary Health
5
NCDs
4
Refugee
3
Specific Hazards
2
Global Health Education
2
Cholera
1
Conflict
1
Zika
1
Polio
1
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
How to address the global crisis in antibiotic research and development.
The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic resistance will continue to develop as long as we ...
O Protocolo de Vigilância Epidemiológica e Sanitária de Eventos Adversos Pós-Vacinação (EAPV), é o documento de referência nacional para a vigilância das vacinas COVID-19. Além disso, complementará, com os demais protocolos definidos pelo Ministério da Saúde, as ações empreendidas par...
Member States have requested WHO policy guidance on how to facilitate the implementation of national AMS activities in an integrated and programmatic approach. This policy guidance responds to that demand from Member States and is anchored in public health guiding principles in the human health sect...
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
The COVID-19 Strategic Preparedness and Response Plan (SPRP) 2021 Monitoring and Evaluation Framework tracks global progress against the COVID-19 SPRP 2021 for the ten pillars of the public health response. The operational intelligence complements the epidemiologic information used to drive a global...
Module appartenant à la série d’évaluations des capacités des services de santé dans le cadre de la pandémie de COVID-19: orientations provisoires, 12 mai 2021. L'outil d'évaluation de la continuité des services de santé essentiels : Facility Assessment Tool peut être utilisé par les pa...
This update of the Guidelines for poison control, entitled Guidelines for establishing a poison centre, reflects the development of the role of poison centres in public health and the sound management of chemicals, described in section 1, and the opportunities provided by new technology. Assessments...
Against this background of nearly 20 years of experience of research, development and
improvement in patient safety, the role of incident and adverse event reporting, as well as the
benefits that derive from it, is still a work in progress.This document has two main purposes:
• to provide an up...
A living WHO guideline on drugs for covid-19
recommended
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access for clarity. The publication of the RE...
module de la série d’évaluation des capacités des services de santé dans le contexte de la pandémie de COVID-19, 7 juillet 2021
Orientations provisoires 19 juillet 2021
interim guidance, 19 July 2021 (arabic version)
Vaccination programmes against COVID-19 and seasonal influenza are currently being implemented in parallel in many countries. Administration of both vaccines during the same visit has potential advantages. This document presents the evidence related to coadministration of Covid-19 and influenza vacc...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
